RKI-1447, a potent ROCK inhibitor with anti-tumor and anti-invasive activities in breast cancer

被引：0
|
作者：
Patel, Ronil A. [1 ]
Forinash, Kara D. [1 ]
Pireddu, Roberta [1 ]
Sun, Ying [1 ]
Martin, Mathew P. [1 ]
Zhu, Jin-Yi [1 ]
Alexander, Brian G. [1 ]
Schonbrunn, Ernst [1 ]
Lawrence, Nicholas J. [1 ]
Sebti, Said M. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2942
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2942
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The genomic and anti-tumor immune evolution of breast cancer.
    Blanco-Heredia, Juan
    Anjos Souza, Carla
    Goncalves-Ribeiro, Samuel
    Gonzalez-Cao, Maria
    Callari, Maurizio
    Tresserra, Francesc
    Rossell, Rafael
    Caldas, Carlos
    De Mattos-Arruda, Leticia
    CANCER RESEARCH, 2021, 81 (13)
  • [42] A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model
    Shicheng Yang
    Gary E. Archer
    Catherine E. Flores
    Duane A. Mitchell
    John H. Sampson
    Cancer Immunology, Immunotherapy, 2013, 62 : 1649 - 1662
  • [43] Discovery of a novel HDM2 inhibitor with potent in vivo anti-tumor activity
    Wang, Yaolin
    Lipari, Philip
    Mirza, Asra
    Lin, Yinghui
    Zhang, Rumin
    Bogen, Stephane
    Bogen, Stephane
    Ma, Yao
    Hicklin, Daniel J.
    Seidel-Dugan, Cynthia
    Liu, Suxing
    Wang, Xiaoying
    Doll, Ronald
    Shipps, Gerald
    Bishop, Walter Robert
    CANCER RESEARCH, 2012, 72
  • [44] FoRx-06-428 is a novel PARG inhibitor with potent anti-tumor efficacy in preclinical cancer models
    Querolle, Olivier
    Lucking, Ulrich
    Iacovino, Luca
    Freudenmann, Alena
    Rossetti, Giacomo
    Gysin, Marina
    Bologna, Serena
    Dionellis, Vasilis
    Malattia, Marta
    Potenza, Alessandro
    Bocquet, Nicolas
    Konstantinova, Irena
    Goutopoulos, Andreas
    Sotiriou, Sotirios
    Halazonetis, Thanos
    Bashir, Tarig
    Zenke, Frank
    CANCER RESEARCH, 2024, 84 (06)
  • [45] A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model
    Yang, Shicheng
    Archer, Gary E.
    Flores, Catherine E.
    Mitchell, Duane A.
    Sampson, John H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (11) : 1649 - 1662
  • [46] In vitro and in vivo anti-tumor activity of ARQ 751, a potent and selective AKT inhibitor
    Yu, Yi
    Savage, Ronald E.
    Eathiraj, Sudharshan
    Hall, Terence
    Schwartz, Brian
    Abbadessa, Giovanni
    CANCER RESEARCH, 2016, 76
  • [47] A novel and potent Cblb inhibitor demonstrates robust immunological profile and anti-tumor efficacy
    Chinnapattu, Murugan
    Shelke, Sandeep
    Ingale, Prashant
    Waghmare, Nayan
    Kadlag, Nanasaheb
    Pawar, Manoj
    Kangane, Akshay
    Chaudhari, Sachin S.
    Saini, Jagmohan
    Kattige, Vidya
    Joshi, Arti
    Dutta, Colina
    Boral, Debjyoti
    Kadam, Sheetal
    Potdar, Varada
    Mani, Jiju
    Sawant, Pooja
    Marathe, Megha
    Mulay, Madhavi
    Virdikar, Akshata
    Mandadi, Sravan
    Akarte, Atul
    Singh, Anuj
    Misra, Chandrasekhar
    Lambade, Pandurang
    Tirumalasetty, Chaitanya
    Patole, Raju
    Karande, Vikas
    Behera, Dayanidhi
    Jain, Pankaj
    Kurawattimath, Vishwanath
    Gowda, Nagaraj
    Iyer, Pravin S.
    CANCER RESEARCH, 2023, 83 (07)
  • [48] Vicrostatin - An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities
    Minea, Radu O.
    Helchowski, Corey M.
    Zidovetzki, Samuel J.
    Costa, Fritz K.
    Swenson, Stephen D.
    Markland, Francis S., Jr.
    PLOS ONE, 2010, 5 (06):
  • [49] Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2+ Breast Cancer
    Alwarawrah, Yazan
    Hughes, Philip
    Loiselle, David
    Carlson, David A.
    Darr, David B.
    Jordan, Jamie L.
    Xiong, Jessie
    Hunter, Lucas M.
    Dubois, Laura G.
    Thompson, J. Will
    Kulkarni, Manjusha M.
    Ratcliff, Annette N.
    Kwiek, Jesse J.
    Haystead, Timothy A. J.
    CELL CHEMICAL BIOLOGY, 2016, 23 (06): : 678 - 688
  • [50] Anti-tumor and Anti-cancer Stem Cell Activity of a Poly ADP-ribose Polymerase Inhibitor Olaparib in Breast Cancer Cells
    Shimo, T.
    Kurebayashi, J.
    Kanomata, N.
    Yamashita, T.
    Moriya, T.
    Sonoo, H.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S93 - S93
12345